Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study

BACKGROUND: Gentamicin is used as a therapeutic agent for Ménière’s disease because of its vestibulotoxicity causing chemo-ablation of the vestibular sensory epithelia. Its use has increased in recent years. However, there is still no consensus about the dose regimen of gentamicin in the treatment o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bremer, Hendrik G, van Rooy, Ingrid, Pullens, Bas, Colijn, Carla, Stegeman, Inge, van der Zaag-Loonen, Hester J, van Benthem, Peter Paul, Klis, Sjaak F L, Grolman, Wilko, Bruintjes, Tjasse D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Methodology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141100/
https://ncbi.nlm.nih.gov/pubmed/25135244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-328
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak